Lung Cancer Considered

By IASLCScience

Lung Cancer Considered episodes

April 27, 2020 COVID-19 Guidelines for Patients with Lung Cancer with Dr. Erin Bange
The newest episode of Lung Cancer Considered, the IASLC's official podcast program, focuses on a collection of journal articles and guidelines about COVID-19 in patients with lung cancer. This episode features a conversation between IASLC Chief Science Officer, Dr. Chandra Belani and Dr. Erin Bange, oncology fellow of the University of Pennsylvania School of Medicine.
30 min
April 20, 2020 JTO Study on Smoking Cessation Impact with Dr. Rafael Meza
The newest episode of Lung Cancer Considered, the IASLC's official podcast program, focuses on the recent Journal of Thoracic Oncology study, "Potential Impact of Cessation Interventions at the Point of Lung Cancer Screening on Lung Cancer and Overall Mortality in the United States." This episode features a conversation between Dr. Jack West and Dr. Rafael Meza, associate professor in the department of epidemiology and co-leader of the cancer epidemiology and prevention program at the University of Michigan Rogel Cancer Center.
25 min
April 06, 2020 COVID-19 JTO Report with Dr. Shu-Yuan Xiao
This episode features Dr. Shu-Yuan Xiao, professor of pathology at the University of Chicago and Lung Cancer Considered host Dr. Jack West discussing a COVID-19 report that was recently published in the Journal of Thoracic Oncology. The study covers the pathology of two COVID-19 positive patients from Wuhan who were originally treated for lung cancer.
41 min
March 31, 2020 COVID-19 Facts and Impacts for the Lung Cancer Community
This episode features Janet Freeman- Daily, writer, lung cancer patient, advocate and Twitter chat moderator of the Lung Cancer Social Media chat (#LCSMchat), she is joined by Dr. Amy Moore, Director of Science and Research at the Go2 Foundation, Dr. Upal Basu Roy, Vice President of Research at LUNGevity Foundation, and Dr. Lecia Sequist, Director of Center for Innovation and Early Cancer Detection at Massachusetts General Hospital and the Landry Family Associate Professor of Medicine at Harvard Medical School. Together they discuss the impact of the COVID-19 epidemic on lung cancer patients and healthcare providers.
34 min
March 16, 2020 Interview with IASLC President- Dr. Tetsuya Mitsudomi
This episode features a conversation between Dr. Marty Edelman, Chair of the Department of Hematology/Oncology and a Professor, Department of Hematology/Oncology at Fox Chase Cancer Center and IASLC President, Dr. Tetsuya Mitsudomi, a Professor at the Division of Thoracic Surgery, Department of Surgery at Kindai University Faculty of Medicine in Osaka-Sayama, Japan. Together they discuss highlights of Dr. Mitsudomi's career, his goals as President of IASLC and what his hopes are for the future of lung cancer research.
23 min
March 02, 2020 Highlights from 20th IASLC 2020 Lung Cancer Targeted Therapies Conference
This episode features Dr. Marty Edelman, Chair of the Department of Hematology/Oncology and a Professor, Department of Hematology/Oncology at Fox Chase Cancer Center. He is joined by Dr. Roy Herbst, a Professor of Medicine and Pharmacology, Chief of Medical Oncology, and Associate Director for Translational Research at Yale Cancer Center/ Yale School of Medicine; and Dr. Leora Horn, the Ingram Associate Professor of Cancer Research at Vanderbilt Ingram Cancer Center and Clinical Director, Thoracic Oncology Program. Together they discuss highlights from the 20th IASLC 2020 Lung Cancer Targeted Therapies conference in Santa Monica
22 min
February 17, 2020 IASLC 2020 Lung Cancer Targeted Therapies Meeting
This episode features Janet Freeman- Daily, writer, lung cancer patient, advocate and Twitter chat moderator of the Lung Cancer Social Media chat (#LCSMchat), she is joined by Dr. Paul Bunn, a distinguished professor and Dudley Endowed Chair at the University of Colorado Comprehensive Cancer Center and IASLC Past President and Past CEO; as well as Dr. Suresh Ramalingam, Roberto Goizueta Chair in Cancer Research, Winship Cancer Institute of Emory University. Together they discuss the upcoming IASLC 2020 Lung Cancer Targeted Therapies meeting in Santa Monica.
25 min
February 04, 2020 Interview with IASLC Chief Science Officer Dr. Chandra Belani
This episode features a conversation between Dr. Heather Wakelee, Professor of Medicine in the Division of Oncology at Stanford University and faculty director of the Stanford Cancer Clinical Trials Office and current president-elect of the IASLC and Dr. Chandra Belani, professor of Medicine in the Division of Hematology/Oncology in the Department of Medicine at the Penn State Hershey Medical Center in Hershey, Penn. The interview covers Dr. Belani’s new position as chief science officer for the IASLC and the history of his involvement with lung cancer.
26 min
January 21, 2020 American Cancer Society Report with CSO Dr. Chandra Belani
This episode features a conversation between Dr. Heather Wakelee, professor of Medicine in the Division of Oncology at Stanford University and faculty director of the Stanford Cancer Clinical Trials Office and current president-elect of the IASLC and Dr. Chandra Belani, professor of Medicine in the Division of Hematology/Oncology at the Penn State Hershey Medical Center in Hershey, Penn., and the chief science officer for the IASLC. Together they discuss a recent study from the American Cancer Society that reported a significant drop in the cancer mortality rate, led largely by progress in lung cancer.
17 min
January 07, 2020 E-Cigarette and Vaping Policy with Dr. Matthew Steliga
This episode features a conversation between David Mesko, the chief executive officer of IASLC and Dr. Matt Steliga, chair of The IASLC Tobacco Control and Smoking Cessation Committee and surgical oncologist at Winthrop P. Rockefeller Cancer Institute, Little Rock, Ark. The two discussed the e-cigarettes and vaping and IASLC’s leadership on this developing public health issue.
19 min

About Lung Cancer Considered

From the publisher's feed

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.